These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 18778390

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.
    Lawrinson P, Ali R, Buavirat A, Chiamwongpaet S, Dvoryak S, Habrat B, Jie S, Mardiati R, Mokri A, Moskalewicz J, Newcombe D, Poznyak V, Subata E, Uchtenhagen A, Utami DS, Vial R, Zhao C.
    Addiction; 2008 Sep; 103(9):1484-92. PubMed ID: 18636999
    [Abstract] [Full Text] [Related]

  • 7. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD, Grebely J, Tossonian H, Wong T, Viljoen M, Khara M, Mead A, McLean M, Duncan F, Petkau AJ, DeVlaming S, Conway B.
    Drug Alcohol Depend; 2007 Jul 10; 89(2-3):306-9. PubMed ID: 17383117
    [Abstract] [Full Text] [Related]

  • 8. Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine.
    Schaub M, Chtenguelov V, Subata E, Weiler G, Uchtenhagen A.
    Int J Drug Policy; 2010 May 10; 21(3):229-33. PubMed ID: 19926271
    [Abstract] [Full Text] [Related]

  • 9. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E.
    Antivir Ther; 2004 Jun 10; 9(3):407-14. PubMed ID: 15259903
    [Abstract] [Full Text] [Related]

  • 10. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C, Raffi F, Roux P, Reynes J, Dellamonica P, Spire B, Leport C, Carrieri MP, ANRS CO8 APROCO-COPILOTE Study Group.
    J Antimicrob Chemother; 2009 Sep 10; 64(3):599-606. PubMed ID: 19602563
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R, Langohr K, Tor J, Sanvisens A, Serra I, Rey-Joly C, Muñoz A.
    Clin Infect Dis; 2007 Aug 01; 45(3):370-6. PubMed ID: 17599317
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V, Ponce-de-León S, Anaya-Saavedra G, Crabtree Ramírez B, Sierra-Madero J.
    Clin Infect Dis; 2007 Oct 01; 45(7):925-32. PubMed ID: 17806063
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
    Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS.
    CMAJ; 2003 Sep 30; 169(7):656-61. PubMed ID: 14517122
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.